These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
44. A heterozygous deletion mutation in the cardiac sodium channel gene SCN5A with loss- and gain-of-function characteristics manifests as isolated conduction disease, without signs of Brugada or long QT syndrome. Zumhagen S; Veldkamp MW; Stallmeyer B; Baartscheer A; Eckardt L; Paul M; Remme CA; Bhuiyan ZA; Bezzina CR; Schulze-Bahr E PLoS One; 2013; 8(6):e67963. PubMed ID: 23840796 [TBL] [Abstract][Full Text] [Related]
45. Hydrocinnamic Acid Inhibits the Currents of WT and SQT3 Syndrome-Related Mutants of Kir2.1 Channel. Ren S; Pang C; Huang Y; Xing C; Zhan Y; An H J Membr Biol; 2017 Oct; 250(5):425-432. PubMed ID: 28660286 [TBL] [Abstract][Full Text] [Related]
46. Trafficking-competent KCNQ1 variably influences the function of HERG long QT alleles. Hayashi K; Shuai W; Sakamoto Y; Higashida H; Yamagishi M; Kupershmidt S Heart Rhythm; 2010 Jul; 7(7):973-80. PubMed ID: 20348026 [TBL] [Abstract][Full Text] [Related]
48. The N-terminal juxtamembranous domain of KCNQ1 is critical for channel surface expression: implications in the Romano-Ward LQT1 syndrome. Dahimène S; Alcoléa S; Naud P; Jourdon P; Escande D; Brasseur R; Thomas A; Baró I; Mérot J Circ Res; 2006 Nov; 99(10):1076-83. PubMed ID: 17053194 [TBL] [Abstract][Full Text] [Related]
49. Characterization of a novel mutant KCNQ1 channel subunit lacking a large part of the C-terminal domain. Kimoto K; Kinoshita K; Yokoyama T; Hata Y; Komatsu T; Tsushima E; Nishide K; Yamaguchi Y; Mizumaki K; Tabata T; Inoue H; Nishida N; Fukurotani K Biochem Biophys Res Commun; 2013 Oct; 440(2):283-8. PubMed ID: 24070608 [TBL] [Abstract][Full Text] [Related]
50. The G314S KCNQ1 mutation exerts a dominant-negative effect on expression of KCNQ1 channels in oocytes. Li W; Du R; Wang QF; Tian L; Yang JG; Song ZF Biochem Biophys Res Commun; 2009 May; 383(2):206-9. PubMed ID: 19348785 [TBL] [Abstract][Full Text] [Related]
51. Overlapping LQT1 and LQT2 phenotype in a patient with long QT syndrome associated with loss-of-function variations in KCNQ1 and KCNH2. Cordeiro JM; Perez GJ; Schmitt N; Pfeiffer R; Nesterenko VV; Burashnikov E; Veltmann C; Borggrefe M; Wolpert C; Schimpf R; Antzelevitch C Can J Physiol Pharmacol; 2010 Dec; 88(12):1181-90. PubMed ID: 21164565 [TBL] [Abstract][Full Text] [Related]
52. A double-point mutation in the selectivity filter site of the KCNQ1 potassium channel results in a severe phenotype, LQT1, of long QT syndrome. Ikrar T; Hanawa H; Watanabe H; Okada S; Aizawa Y; Ramadan MM; Komura S; Yamashita F; Chinushi M; Aizawa Y J Cardiovasc Electrophysiol; 2008 May; 19(5):541-9. PubMed ID: 18266681 [TBL] [Abstract][Full Text] [Related]
53. A PIP Liu Y; Xu X; Gao J; Naffaa MM; Liang H; Shi J; Wang HZ; Yang ND; Hou P; Zhao W; White KM; Kong W; Dou A; Cui A; Zhang G; Cohen IS; Zou X; Cui J Commun Biol; 2020 Jul; 3(1):385. PubMed ID: 32678288 [TBL] [Abstract][Full Text] [Related]
54. Characterization of an LQT5-related mutation in KCNE1, Y81C: implications for a role of KCNE1 cytoplasmic domain in IKs channel function. Wu DM; Lai LP; Zhang M; Wang HL; Jiang M; Liu XS; Tseng GN Heart Rhythm; 2006 Sep; 3(9):1031-40. PubMed ID: 16945797 [TBL] [Abstract][Full Text] [Related]
55. Novel KCNE3 mutation reduces repolarizing potassium current and associated with long QT syndrome. Ohno S; Toyoda F; Zankov DP; Yoshida H; Makiyama T; Tsuji K; Honda T; Obayashi K; Ueyama H; Shimizu W; Miyamoto Y; Kamakura S; Matsuura H; Kita T; Horie M Hum Mutat; 2009 Apr; 30(4):557-63. PubMed ID: 19306396 [TBL] [Abstract][Full Text] [Related]
56. Mechanisms of disease pathogenesis in long QT syndrome type 5. Harmer SC; Wilson AJ; Aldridge R; Tinker A Am J Physiol Cell Physiol; 2010 Feb; 298(2):C263-73. PubMed ID: 19907016 [TBL] [Abstract][Full Text] [Related]
57. Biophysical characteristics of a new mutation on the KCNQ1 potassium channel (L251P) causing long QT syndrome. Deschênes D; Acharfi S; Pouliot V; Hegele R; Krahn A; Daleau P; Chahine M Can J Physiol Pharmacol; 2003 Feb; 81(2):129-34. PubMed ID: 12710526 [TBL] [Abstract][Full Text] [Related]
58. Molecular Mechanism of Autosomal Recessive Long QT-Syndrome 1 without Deafness. Oertli A; Rinné S; Moss R; Kääb S; Seemann G; Beckmann BM; Decher N Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33498651 [No Abstract] [Full Text] [Related]
59. Regulation of Kv2.1 channel inactivation by phosphatidylinositol 4,5-bisphosphate. Delgado-Ramírez M; De Jesús-Pérez JJ; Aréchiga-Figueroa IA; Arreola J; Adney SK; Villalba-Galea CA; Logothetis DE; Rodríguez-Menchaca AA Sci Rep; 2018 Jan; 8(1):1769. PubMed ID: 29379118 [TBL] [Abstract][Full Text] [Related]
60. Biophysical properties of mutant KCNQ1 S277L channels linked to hereditary long QT syndrome with phenotypic variability. Aidery P; Kisselbach J; Schweizer PA; Becker R; Katus HA; Thomas D Biochim Biophys Acta; 2011 Apr; 1812(4):488-94. PubMed ID: 21241800 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]